KineMed and CHDI Foundation Announce Study to Investigate Role of Brain Cholesterol Synthesis and Lipid Metabolism in Huntington’s Disease
09:00 EDT 13 Jun 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
KineMed Inc. (www.kinemed.com)
and CHDI Foundation, Inc. announced today a collaboration to investigate
the role of the metabolism of cholesterol and other lipids in
Huntington’s disease (HD). Research leading up to this study...
Other Sources for this Article
KineMed Inc.
Lila Taylor, 510-655-6525 ext. 141
Director
of Alliance Management
ltaylor@kinemed.com
More From BioPortfolio on "KineMed and CHDI Foundation Announce Study to Investigate Role of Brain Cholesterol Synthesis and Lipid Metabolism in Huntington’s Disease"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
